Xerese NDC 0187-5104

NDC codes

FDA NDC Directory

Product NDC (as listed)0187-5104Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00187-5104Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0187-5104-01	00187510401	1 TUBE in 1 CARTON (0187-5104-01) / 5 g in 1 TUBEMarketed from Jul 31, 2009

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Xerese
Generic name (nonproprietary): acyclovir and hydrocortisone
Active ingredients: Acyclovir — 50 mg/gHydrocortisone — 10 mg/g
Dosage form: Cream
Route: Topical
Labeler: Bausch Health US LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022436
Marketing start: Jul 31, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 0187-5104_a4efb63c-e7bf-43da-bbfe-463f672cb1bcSPL ID a4efb63c-e7bf-43da-bbfe-463f672cb1bcSPL set ID 3b6ac164-0f1e-4f36-94a1-1fdb07d710f5RxCUI 998422, 998426UNII X4HES1O11F, WI4X0X7BPJ
Pharmacologic class: Corticosteroid; Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400187510401 followed by a unit qualifier and the quantity

Package 00187-5104-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 3, 2020.

Indications (excerpt from the label)

XERESE, a combination of acyclovir, a herpes simplex virus deoxynucleoside analog DNA polymerase inhibitor, and hydrocortisone, a corticosteroid, is indicated for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and children (6 years of age and older). XERESE, a combination of acyclovir, a herpes simplex virus deoxynucleoside analog DNA polymerase inhibitor, and hydrocortisone, a corticosteroid, is indicated for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and childre…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)